TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited has reported a positive cash flow from operating activities for the quarter ending June 30, 2025, amounting to $170,000, supported by government grants and tax incentives totaling $489,000. The company also secured $247,000 from financing activities, resulting in a net increase in cash and cash equivalents of $63,000 for the period, indicating a stable financial position and potential for future growth.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation products. The company is primarily engaged in research and development, product manufacturing, and marketing activities related to its inhalation technologies.
Average Trading Volume: 329,510
Technical Sentiment Signal: Buy
Current Market Cap: A$8.96M
For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.